We are live on ! Find out more
BCM

Bayesian Capital Management Portfolio holdings

AUM $81.9M
1-Year Est. Return 26.59%
This Fund
S&P 500
This Quarter Est. Return
-1.32%
1 Year Est. Return
+26.59%
3 Year Est. Return
+112.98%
5 Year Est. Return
+129.77%
10 Year Est. Return
+1,146.62%
AUM
$493M
AUM Growth
-$43.7M
Cap. Flow
-$6.65M
Cap. Flow %
-1.35%
Top 10 Hldgs %
14.21%
Holding
1,115
New
370
Increased
135
Reduced
155
Closed
453

Top Sells

Rank Stock Value
1
TFC icon
Truist Financial
TFC
+$6.76M
2
QCOM icon
Qualcomm
QCOM
+$6.11M
3
WBA
Walgreens Boots Alliance
WBA
+$4.04M
4
EOG icon
EOG Resources
EOG
+$4.02M
5
TMUS icon
T-Mobile US
TMUS
+$3.82M

Sector Composition

Rank Sector Weight
1 Technology 24.08%
2 Healthcare 13.66%
3 Consumer Discretionary 12.3%
4 Industrials 9.83%
5 Financials 9.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CB icon
26
Chubb
CB
$139B
$3.06M 0.62%
16,800
+8,058
+92% +$1.53M
NVDA icon
27
NVIDIA
NVDA
$4.76T
$3.02M 0.61%
+249,000
New +$3.94M
B
28
Barrick Mining
B
$62.6B
$2.92M 0.59%
188,100
+160,200
+574% +$2.53M
ZEN
29
DELISTED
ZENDESK INC
ZEN
$2.9M 0.59%
+38,067
New +$2.89M
DIS icon
30
Walt Disney
DIS
$168B
$2.83M 0.57%
29,994
+6,100
+26% +$653K
LW icon
31
Lamb Weston
LW
$7.3B
$2.74M 0.56%
+35,434
New +$2.77M
HUM icon
32
Humana
HUM
$45.8B
$2.72M 0.55%
+5,600
New +$2.72M
DHR icon
33
Danaher
DHR
$138B
$2.63M 0.53%
+11,476
New +$2.81M
IWM icon
34
iShares Russell 2000 ETF
IWM
$80.3B
$2.57M 0.52%
15,600
-12,700
-45% -$2.32M
BBBY
35
DELISTED
Bed Bath & Beyond Inc
BBBY
$2.4M 0.49%
+393,278
New +$3.2M
ADI icon
36
Analog Devices
ADI
$181B
$2.37M 0.48%
17,020
+10,100
+146% +$1.6M
JD icon
37
JD.com
JD
$41.8B
$2.33M 0.47%
+46,395
New +$2.75M
FANG icon
38
Diamondback Energy
FANG
$55.1B
$2.33M 0.47%
+19,300
New +$2.41M
TMO icon
39
Thermo Fisher Scientific
TMO
$208B
$2.32M 0.47%
4,578
+2,211
+93% +$1.24M
XRAY icon
40
Dentsply Sirona
XRAY
$2.61B
$2.3M 0.47%
81,050
+75,400
+1,335% +$2.58M
P
41
Everpure Inc
P
$24.7B
$2.29M 0.46%
83,642
+12,500
+18% +$353K
O icon
42
Realty Income
O
$61.1B
$2.21M 0.45%
38,060
+22,400
+143% +$1.54M
VYX icon
43
NCR Voyix
VYX
$1.13B
$2.19M 0.44%
187,939
+108,232
+136% +$1.99M
XBI icon
44
State Street SPDR S&P Biotech ETF
XBI
$10.2B
$2.09M 0.42%
26,400
-3,542
-12% -$299K
FAST icon
45
Fastenal
FAST
$54.7B
$2.06M 0.42%
89,516
+58,800
+191% +$1.48M
NVS icon
46
Novartis
NVS
$297B
$2.05M 0.42%
+26,993
New +$2.24M
U icon
47
Unity
U
$13.3B
$2.01M 0.41%
+63,012
New +$2.59M
COUP
48
DELISTED
Coupa Software Incorporated
COUP
$1.96M 0.4%
33,400
+2,900
+10% +$190K
M icon
49
Macy's
M
$6.57B
$1.94M 0.39%
+123,900
New +$2.19M
TJX icon
50
TJX Companies
TJX
$173B
$1.92M 0.39%
30,900
-25,900
-46% -$1.63M

Similar funds

Bayesian Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, Bayesian Capital Management held 1,115 positions worth $493M, down 8.1% from $537M the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Bayesian Capital Management's Q3 2022 filing shows 370 new, 135 increased, 155 reduced and 453 closed positions. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 39,700 shares worth $14.2M. The largest sale was Truist Financial, an estimated $6.76M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Bayesian Capital Management's largest Q3 2022 buy was State Street SPDR S&P 500 ETF Trust: 39,700 shares worth $14.2M.
  • Bayesian Capital Management added most to Medtronic in Q3 2022, an estimated $7.24M increase.
  • Bayesian Capital Management's biggest Q3 2022 reduction was Truist Financial, cutting an estimated $6.76M.
  • Bayesian Capital Management fully exited Walgreens Boots Alliance in Q3 2022, selling an estimated $4.04M.
  • Bayesian Capital Management's ten largest holdings make up 14% of its $493M portfolio in Q3 2022.
  • Bayesian Capital Management opened 370 new positions and closed 453 in Q3 2022.
  • Bayesian Capital Management's portfolio value fell 8.1% quarter-over-quarter to $493M.

Based on Bayesian Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.